These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33521418)

  • 1. Extracellular Nanovesicles: From Intercellular Messengers to Efficient Drug Delivery Systems.
    Deshmukh SK; Khan MA; Singh S; Singh AP
    ACS Omega; 2021 Jan; 6(3):1773-1779. PubMed ID: 33521418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Potential of Nucleic Acids when Combined with Extracellular Vesicles.
    Jurgielewicz B; Stice S; Yao Y
    Aging Dis; 2021 Sep; 12(6):1476-1493. PubMed ID: 34527423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving antiproliferative effect of the nevirapine on Hela cells by loading onto chitosan coated magnetic nanoparticles as a fully biocompatible nano drug carrier.
    Moghadam NH; Salehzadeh S; Rakhtshah J; Tanzadehpanah H; Moghadam AH; Hajibabaei F; Sharifinia S; Asl SS; Saidijam M
    Int J Biol Macromol; 2018 Oct; 118(Pt A):1220-1228. PubMed ID: 30001607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing the Therapeutic Potential of Extracellular Vesicles Using Peptide Technology.
    Martin Perez C; Conceição M; Raz R; Wood MJA; Roberts TC
    Methods Mol Biol; 2022; 2383():119-141. PubMed ID: 34766286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Vesicles as Delivery Vehicles for Therapeutic Nucleic Acids in Cancer Gene Therapy: Progress and Challenges.
    Du R; Wang C; Zhu L; Yang Y
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles: powerful candidates in nano-drug delivery systems.
    Liu X; Cao Y; Wang S; Liu J; Hao H
    Drug Deliv Transl Res; 2024 Feb; 14(2):295-311. PubMed ID: 37581742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-based therapies for mucosal delivery.
    Peswani Sajnani SL; Zhang Y; Vllasaliu D
    Int J Pharm; 2021 Oct; 608():121087. PubMed ID: 34530100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
    Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R
    Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
    Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
    Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management.
    Almeida C; Teixeira AL; Dias F; Morais M; Medeiros R
    Biology (Basel); 2023 Apr; 12(5):. PubMed ID: 37237479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Vesicle- and Extracellular Vesicle Mimetics-Based Drug Delivery Systems: New Perspectives, Challenges, and Clinical Developments.
    Gangadaran P; Ahn BC
    Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32403320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinspired soft nanovesicles for site-selective cancer imaging and targeted therapies.
    Prasad R; Conde J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1792. PubMed ID: 35318815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
    Meng W; He C; Hao Y; Wang L; Li L; Zhu G
    Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles: Emerging tools as therapeutic agent carriers.
    Liu S; Wu X; Chandra S; Lyon C; Ning B; Jiang L; Fan J; Hu TY
    Acta Pharm Sin B; 2022 Oct; 12(10):3822-3842. PubMed ID: 36213541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver.
    Marcus ME; Leonard JN
    Pharmaceuticals (Basel); 2013; 6(5):659-80. PubMed ID: 23894228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
    Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.